Investor Relations | Financial Information

Capex, Depeciation, R&D

Unit:Yen millions / Fiscal Year 2017/3 2018/3 2019/3 2020/3 2021/3
Investment in facilities
Share of cash flow (%)
167,631
72.1
178,612
114.8
173,592
91.9
173,429
94.9
212,355
96.7
Depreciation expenses
Share of net sales (%)
87,491
7.4
92,171
7.2
106,631
7.7
124,984
9.2
140,285
9.5
Cash flow
(Net income + Depreciation expenses)
232,590 155,634 188,836 182,764 219,625
Research and development expenses
 Share of net sales (%)
91,254
7.7
102,641
8.1
115,155
8.3
117,489
8.6
127,046
8.6

Recommendations

  •  
  •  
  •